50 mg Eltrombopag Tablets

Get a Price/Quote

50 mg Eltrombopag Tablets Specification

Origin of Medicine
India

Packaging Type
Blister Pack in Carton Box

Brand Name
Eltroxin (Example: substitute with actual brand if available)

Pacakaging (Quantity Per Box)
30 Tablets

Life Span
24 Months from the date of manufacture

Dosage Form
Oral Tablet

Indication
Thrombocytopenia, Severe Aplastic Anemia

Salt Composition
Eltrombopag Olamine

Drug Type
Allopathic

Ingredients
Eltrombopag Olamine

Physical Form
Tablets

Function
Platelet production stimulator

Recommended For
Patients with Chronic Immune Thrombocytopenia (ITP), Hepatitis C Associated Thrombocytopenia, Severe Aplastic Anemia

Dosage
As prescribed by the physician

Dosage Guidelines
Take on an empty stomach, at least 1-2 hours before or after meals, as directed by a healthcare professional

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Contraindications
Known hypersensitivity to Eltrombopag or any excipients

Drug Interactions
May interact with antacids, dairy products, and drugs affecting liver enzymes

Regulatory Approval
Approved by Indian regulatory agencies (check with specific manufacturer)

Shape
Round or oval (depending on manufacturer)

Prescription Required
Yes

Route of Administration
Oral

Patient Counselling Information
Do not take with food high in calcium, magnesium, aluminum, iron, or other mineral supplements within 4 hours of dosage

Strength
50 mg

Color
Brownish-orange (may vary by manufacturer)

Side Effects
Nausea, diarrhea, increased liver enzymes, headache

About 50 mg Eltrombopag Tablets

Procure the blue-ribbon 50 mg Eltrombopag Tablets for a sizzling edge in managing thrombocytopenia. These top-drawer oral tablets are remarked for their efficacy in boosting platelet production, prescribed primarily for chronic immune thrombocytopenia, hepatitis C-associated thrombocytopenia, and severe aplastic anemia. Offered at an unbeatable price, each box contains 30 brownish-orange tablets, ensuring practical dosage over a 24-month shelf life. Manufactured in India, these allopathic tablets require a valid prescription and are delivered in a secure blister pack for your assurance.

Application, Benefits, and Competitive Edge

Eltrombopag 50 mg tablets are administered orally on an empty stomach, at least 1-2 hours before or after food, optimizing absorption. Used as a platelet production stimulator, they offer a prominent advantage for patients requiring reliable management of low platelet counts. This product stands out due to its blue-ribbon formulation, blister packaging for lasting efficacy, and the unbeatable price, providing an effective, safe, and convenient therapeutic choice for adults.

Domestic Supply, Order Terms, and Regulatory Certifications

Backed by a robust domestic market network, these tablets are supplied efficiently across India upon receipt of a purchase order. Transportation adheres to safety protocols, ensuring products arrive undamaged and within stated timeframes. Payment terms are flexible, catering to various client requirements. Each batch is certified by Indian regulatory agencies, ensuring compliance, quality, and safe usage for healthcare providers and patients alike.

FAQ's of 50 mg Eltrombopag Tablets:

Q: How should I take the 50 mg Eltrombopag Tablets for optimal results?

A: These tablets must be taken on an empty stomach, at least 1-2 hours before or after food, and not with dairy products, antacids, or iron supplements within four hours to ensure maximum absorption.

Q: What conditions are the 50 mg Eltrombopag Tablets used for?

A: Eltrombopag 50 mg tablets are prescribed for adults with chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia, to help stimulate platelet production.

Q: When is a prescription mandatory for procuring these tablets?

A: A valid doctor's prescription is required for purchasing Eltrombopag 50 mg tablets, as this is a regulated medication meant for specific medical conditions.

Q: Where are the 50 mg Eltrombopag Tablets manufactured and what certifications do they have?

A: These tablets are manufactured in India and approved by relevant Indian regulatory agencies. The specific certification may vary according to the manufacturer, so check packaging for further details.

Q: What primary advantages do these tablets offer compared to alternatives?

A: The tablets are known for their consistent efficacy, blue-ribbon manufacturing standards, practical blister packaging, and an unbeatable price, making them a preferred therapeutic option for eligible patients.